The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Exclusively targeting β-secretase to lipid rafts by GPI-anchor addition up-regulates β-site processing of the amyloid precursor protein
Open accessAbstract
β-Secretase (BACE, Asp-2) is a transmembrane aspartic proteinase responsible for cleaving the amyloid precursor protein (APP) to generate the soluble ectodomain sAPPβ and its C-terminal fragment CTFβ. CTFβ is subsequently cleaved by γ-secretase to produce the neurotoxic/synaptotoxic amyloid-β peptide (Aβ) that accumulates in Alzheimer's disease. Indirect evidence has suggested that amyloidogenic APP processing may preferentially occur in lipid rafts. Here, we show that relatively little wild-type BACE is found in rafts prepared from a human neuroblastoma cell line (SH-SY5Y) by using Triton X-100 as detergent. To investigate further the significance of lipid rafts in APP processing, a glycosylphosphatidylinositol (GPI) anchor has been added to BACE, replacing the transmembrane and C-terminal domains. The GPI anchor targets the enzyme exclusively to lipid raft domains. Expression of GPIBACE substantially up-regulates the secretion of both sAPPβ and amyloid-β peptide over levels observed from cells overexpressing wild-type BACE. This effect was reversed when the lipid rafts were disrupted by depleting cellular cholesterol levels. These results suggest that processing of APP to the amyloid-β peptide occurs predominantly in lipid rafts and that BACE is the rate-limiting enzyme in this process. The processing of the APP 695 isoform by GPI-BACE was up-regulated 20-fold compared with wild-type BACE, whereas only a 2-fold increase in the processing of APP 751/770 was seen, implying a differential compartmentation of the APP isoforms. Changes in the local membrane environment during aging may facilitate the cosegregation of APP and BACE leading to increased β-amyloid production.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“APOE isoforms likely influence Aβ production by modulating lipid metabolism and the lipid composition of cellular membranes, with APOE4 promoting amyloidogenic APP cleavage and Aβ production more than APOE3 [8–10].”
In the citing paper
“APOE modulates APP metabolism in an isoform-dependent manner through distinct mechanisms: 1) influencing APP processing via effects on lipid metabolism [8–10], and 2) modulating Aβ clearance and aggregation via the formation of APOE-Aβ complexes [11, 12].”
In the citing paper
“Aβ peptides are produced primarily by neurons via the sequential cleavage of amyloid precursor protein (APP) by β- and γ-secretases (amyloidogenic pathway) at lipid rafts in the plasma membrane (PM) [35–37].”
From Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation (2023) · cites this paper as [36]
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Lipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Brown, D. A., & Rose, J. K. (1992) · Cell · doi:10.1016/0092-8674(92)90189-j · Cited by 2,921
Statins and the risk of dementia
Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S. S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,764
Purification and cloning of amyloid precursor protein β-secretase from human brain
Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., et al. (1999) · Nature · doi:10.1038/990114 · Cited by 1,612
Wolozin, B. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1439 · Cited by 1,408
Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons
Simons, M., Keller, P., Strooper, B. D., Beyreuther, K. T., Dotti, C. G., & Simons, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6460 · Cited by 1,177
Tanzi, R. E., McClatchey, A. I., Lamperti, E. D., Villa‐Komaroff, L., Gusella, J. F., & Neve, R. L. (1988) · Nature · doi:10.1038/331528a0 · Cited by 1,093
Research works printed but not linked: 1
- Refolo, L. M., Malester, B., LaFrancois, J., Bryant-Thomas, T., Wang, R., Tint, G. S., Sambamurti, K., Duff, K. & Pappolla, M. A. (2000) Neurobiol. Dis. 4, 321–331.
Cited by
Sorted by citations
Items 301–354 of 354
Corraliza-Gómez, M., Guilarte, B. B., Sandonís-Camarero, D., Mondejar-Duran, J., Villa, M., Poncela, M., Valero, J., Sánchez, D., & Ganfornina, M. D. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1112930 · Cited by 4
A New Interpretative Paradigm for Conformational Protein Diseases
Agnati, L. F., Guidolin, D., Woods, A. S., Ciruela, F., Carone, C., Vallelunga, A., Escuela, D. O. B., Genedani, S., & Fuxé, K. (2013) · Current Protein and Peptide Science · doi:10.2174/1389203711314020006 · Cited by 4
Cholesterol and Alzheimer’s Disease
Cordy, J. M., & Wolozin, B. L. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_9 · Cited by 4
Self-citationAPP Biology, Processing and Function
Thinakaran, G., & Koo, E. H. (2007) · Springer eBooks · doi:10.1007/978-0-387-35135-3_2 · Cited by 4
miR-137: A therapeutic candidate or a key molecular regulator in Alzheimer's disease?
Wasim, M., Guo, J., Wang, Z., Parveen, R., Chen, R., Wang, Y., & Ma, G. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251352166 · Cited by 3
Biogenesis and transport of membrane domains-potential implications in brain pathologies
Molino, D., & Galli, T. (2013) · Biochimie · doi:10.1016/j.biochi.2013.09.014 · Cited by 3
Telmisartan Improves Memory Impairment in a Mouse Model of Type 2 Diabetes
Tao, D. G., & Dong, R. R. (2016) · Clinical and Experimental Pharmacology · doi:10.4172/2161-1459.1000204 · Cited by 3
Cholesterol and ApoE in Alzheimer’s disease
Potier, M., Hanbouch, L., & Marquer, C. (2018) · OCL · doi:10.1051/ocl/2018038 · Cited by 3
Integrating Data for Modeling Biological Complexity
Hunter, S., & Brayne, C. (2013) · Springer eBooks · doi:10.1007/978-3-642-30574-0_52 · Cited by 3
Cholesterol Lowering and Beyond: Role of Statins in Alzheimer’s Disease
Rebollo, A., Pou, J., & Alegret, M. (2008) · Aging Health · doi:10.2217/1745509x.4.2.171 · Cited by 3
Jasmin, S. B. (2011) · eScholarship@McGill (McGill) · doi:10.82308/52384 · Cited by 3
Amyloid-β and Mitochondrial Membranes: A Missing Link in Alzheimer’s Pathogenesis
Houfkova, A., & Schmidt, M. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05786-z · Cited by 2
Neurochemical Aspects of Alzheimer Disease
Farooqui, A. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-15889-1_1 · Cited by 2
The Amyloid _-Protein and Alzheimer's Disease
Teplow, D. B., Yang, M., Roychaudhuri, R., Pang, E. S., Huynh, T. V., Chen, M., & Beroukhim, S. (2012) · Frontiers in neuroscience · doi:10.1201/b11986-2 · Cited by 2
Lipid Rafts and Amyloid Metabolism: Role in Pathogenesis of Alzheimer’s Disease
Nalivaeva, N. N., & Turner, A. J. (2020) · Российский физиологический журнал им И М Сеченова · doi:10.31857/s0869813920050052 · Cited by 2
Self-citationMembrane Trafficking and Targeting in Alzheimer's Disease
Rajendran, L., & Simons, K. (2009) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-540-87941-1_8 · Cited by 2
Alzheimer's Disease: Clinical Trials and Future Perspectives
Lee, K. S., & Suh, H. S. (2012) · 대한정신약물학회지 · Cited by 2
Nalivaeva, N. N., & Turner, A. J. (2009) · Springer eBooks · doi:10.1007/978-0-387-30378-9_14 · Cited by 2
Self-citationSecretase Processing of Amyloid Precursor Protein (APP) and Neurodegeneration
Marks, N., & Berg, M. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-30379-6_16 · Cited by 2
Hata, S., Saito, Y., & Suzuki, T. (2011) · Wiley eBooks · doi:10.1002/9783527634323.ch8 · Cited by 2
Huttunen, H. J., & Kovacs, D. M. (2007) · Springer eBooks · doi:10.1007/978-0-387-35135-3_6 · Cited by 2
Alzheimer's Disease BACE Proteases
Roßner, S., & Lichtenthaler, S. F. (2008) · Springer eBooks · doi:10.1007/978-0-387-32671-9_11 · Cited by 1
Visualize neuronal membrane cholesterol with split-fluorescent protein tagged YDQA sensor
Xu, Y., Li, S., Xu, Y., Sun, X., Wei, Y., Wang, Y., Li, S., Ji, Y., Hu, K., Xu, Y., et al. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100781 · Cited by 1
Valdez-Gaxiola, C. A., Rosales-Leycegui, F., Gaxiola-Rubio, A., Dumois‐Petersen, S., Gallegos‐Arreola, M. P., Ringman, J. M., & Figuera, L. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167929 · Cited by 1
Amyloidogenic Processing of APP in Lipid Rafts
Lakshmana, M. K., Roy, S., Mi, K., & Kang, D. E. (2010) · The Open Biology Journal · doi:10.2174/18741967010030100021 · Cited by 1
Copper and Alzheimer Disease: The Good, the Bad and the Ugly
Hung, Y. H., Bush, A. I., & Cherny, R. A. (2012) · Springer eBooks · doi:10.1007/978-1-4419-9663-3_30 · Cited by 1
Current and Future Therapies for Alzheimer Disease
Chakrabarty, P., Das, P., & Golde, T. E. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch34 · Cited by 1
Lateral Membrane Structure and Lipid-Protein Interactions
Pérez‐Gil, J., Cruz, A., & de la Serna, J. B. (2006) · Springer eBooks · doi:10.1007/3-540-28435-4_5 · Cited by 1
Ayoub, S. (2007) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-9327 · Cited by 1
Secretases as Pharmacological Targets in Alzheimer's Disease
Hooper, N. M., & Vardy, E. R. L. C. (2007) · Springer eBooks · doi:10.1007/978-0-387-71522-3_7 · Cited by 1
Self-citationEncephalopathies Accompanying Type 1 and Type 2 Diabetes
Sima, A. A. F. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4899-8035-9_8
Schieb, H. (2011) · DuEPublico (University of Duisburg-Essen)
Regulation of expression and cellular release of acetylcholinesterase
Hicks, D. A. (2013) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Increase of Amyloid-Beta Peptide Generation in High Cholesterol Diet Rabbit Brain
Lee, Y.-K., Son, D.-J., Lee, J.-W., Lee, H., Yun, Y.-W., Oh, K., & Hong, J. T. (2007) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2007.15.1.034
INTRACELLULAR DYNAMICS OF ALZHEIMER DISEASE-RELATED PROTEINS
Selivanova, A. V. (2007) · Figshare
PLEIOTROPIC MECHANISMS OF STATIN ACTION IN ALZHEIMER'S DISEASE
Ostrowski, S. M. (2008) · OhioLink ETD Center (Ohio Library and Information Network)
Adipokines and Alzheimer's Disease
Sortino, M. A., Merlo, S., & Spampinato, S. F. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849733434-00130
Alteration of cholesterol homeostasis in the Huntington's disease brain
Kreilaus, F. (2015) · Research Online (University of Wollongong)
Pająk, B., Orzechowski, A., & Gajkowska, B. (2010) · Current Neurobiology
Carter, A. B. (2017) · D-Scholarship@Pitt (University of Pittsburgh)
Neurochemical Aspects of β-Amyloid Cascade Hypothesis for Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00001-x · Cited by 1
Disruption of Cholesterol Homeostasis in Developmental Neurotoxicity
Guizzetti, M., & Costa, L. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804239-7.00057-3
(2006) · Wiley eBooks · doi:10.1002/9780470041000.cedt063
Elgardawi, M. M., Othman, K. A., Mesallati, A., Abdelmalik, A. M., & Idrise, D. W. (2025) · Libyan Journal of Science &Technology · doi:10.37376/ljst.v14i2.7205
Cholesterol and sphingolipids in Alzheimer's disease
Cajuste, S., Devaney, D., Farr, V., & Bhattacharya, S. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-19116-9.00039-7
Exploring ceramide as a novel biomarker and therapeutic target for Alzheimer’s disease
Zhao, W., Liu, X., Yao, Y., Yu, Y., & Hu, Z. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1771302
Sphingolipids associated research in Alzheimer’s disease: an explored trends analysis
Xie, M.-R., Chen, Y., & Yuan, H. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1723883
Investigation of BACE1 as a stress-induced regulator of neuronal metabolism
Findlay, J. A. (2014) · Discovery Research Portal (University of Dundee)
How Does N- and O-Glycosylation Affect the Formation and Accumulation of Amyloid β-Peptide?
Kitazume, S. (2011) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.23.161
Cholesterol and Aβ Production: Methods for Analysis of Altered Cholesterol De Novo Synthesis
Tschäpe, J. A., Grimm, M. O. W., Grimm, H. S., & Hartmann, T. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_22
Metadata
- Authors
- Cordy, J. M., Hussain, I., Dingwall, C., Hooper, N. M., & Turner, A. J.
- Affiliations
- University of Leeds (GB)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-09-22
- Volume
- 100
- Issue
- 20
- Pages
- 11735-11740
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC208827
- OpenAlex
- W2160524771
- Cited by
- 356
- References
- 36
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 7 · 2023: 6 · 2022: 8 · 2021: 7 · 2020: 10 · 2019: 4 · 2018: 5 · 2017: 10 · 2016: 9 · 2015: 5 · 2014: 12 · 2013: 16 · 2012: 30
- FWCI
- 12.29
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- beta-secretase, BACE, amyloid precursor protein, lipid rafts, GPI anchoring, amyloid-beta production, APP processing, cholesterol depletion, APP isoforms, Alzheimer's disease, SH-SY5Y cells
- MeSH terms
- Amino Acid Sequence, Cholesterol, Humans, Hydrolysis, Molecular Sequence Data, Endopeptidases, Protein Processing, Post-Translational, Tumor Cells, Cultured, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Glycosylphosphatidylinositols, Lipid Metabolism, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review